BioBehavioral Diagnosis Co (BioBDx), a developer of attention deficiency/hyperactivity disorder (ADHD) testing devices, raised $5. 1 million in a round of venture capital, according to a new filing by the company to the Securities and Exchange Commission. Five separate investors participated in the bid.
The firm’s Quotient ADHD System accurately measures motion and analyzes shifts in attention to give a clear picture of the core symptom areas of ADHD (also known as ADD) even in the presence of conditions other than ADHD. The Quotient ADHD Test Report should only be interpreted by qualified professionals in conjunction with other clinical information.
Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/BioBehavioral%20Diagnostic/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co
Singapore has always had a progressive healthcare system with prioritizing innovative solutions to the existing…
A Ponzi scheme is a fraudulent investment scheme that aims to give its investors high…
According to the Global Prop tech Survey, 2019 published by KPMG one of the key…
In April 2016, the world witnessed one of the biggest information leaks in history, consisting…
Silent Eight a global technology company that helps combat money laundering and terrorism financing using…
Indian startup Gully Network Retail Pvt Ltd, a retail-tech startup focused on providing services to…
Leave a Comment